Almeda-Valdes P, Velasco DVG, Campos OA, et al. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. Eur J Endocrinol. 2019;180(2):99-107. doi:10.1530/EJE-18-0677
Powe CE, Nodzenski M, Talbot O, et al. Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus. Diabetes. 2018;67(12):2703-2709. doi:10.2337/db18-0203
Nowak C, Hetty S, Salihovic S, et al. Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance. Sci Rep. 2018;8(1):8691. doi:10.1038/s41598-018-26701-0
Gelaye B, Clish CB, Denis M, et al. Metabolomics signatures associated with an oral glucose challenge in pregnant women. Diabetes Metab. 2019;45(1):39-46. doi:10.1016/j.diabet.2018.01.004
Srinivasan S, Kaur V, Chamarthi B, et al. Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care. 2018;41(3):554-561. doi:10.2337/dc17-1386
Kolisnyk B, Guzman MS, Raulic S, et al. ChAT-ChR2-EYFP mice have enhanced motor endurance but show deficits in attention and several additional cognitive domains. J Neurosci. 2013;33(25):10427-38. doi:10.1523/JNEUROSCI.0395-13.2013
Cheng CW, Villani V, Buono R, et al. Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes. Cell. 2017;168(5):775-788.e12. doi:10.1016/j.cell.2017.01.040
Garaulet M, Gómez-Abellán P, Rubio-Sastre P, Madrid JA, Saxena R, Scheer FAJL. Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism. 2015;64(12):1650-7. doi:10.1016/j.metabol.2015.08.003
Maianti JP, McFedries A, Foda ZH, et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature. 2014;511(7507):94-8. doi:10.1038/nature13297
Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-73. doi:10.1038/ng1180